S&P DJI Announces March 2022 Quarterly Rebalance
Filed with ASX · · 10 pages · English
Story so far
Earlier from ImpediMed
- ImpediMed Announces End Stage Renal Disease Trial Agreement
- PREVENT Trial Peer-Reviewed and Published
- Share Purchase Plan Successfully Completed
- AGM Presentation - November 2021
- 2021 Annual General Meeting - Chairmans Address
Later from ImpediMed
- AstraZeneca extends and increases Renal Contract
- Appendix 4C & Quarterly Activities Report
- Lymphoedema Risk Factors Paper Published
- ImpediMed CEO Announces Departure
- Appendix 4C & Quarterly Activities Report - Jun-2022 Qtr
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed